Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

Related Keywords

,Laguna Niguel ,Exchange Commission ,Prnewswire Viking Therapeutics Inc ,Therapeutics Inc ,Ligand Pharmaceuticals Incorporated ,Twitter ,Obesity Society ,Nasdaq ,Three Clinical Programs Expected ,Data Expected ,Quarter Ended December ,Brian Lian ,Evaluating Dual ,Global Biopharma ,Annual Roth ,Annual Healthcare ,Annual Needham Healthcare ,Months Ended December ,Viking Therapeutics ,Ligand Pharmaceuticals ,Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Nc ,